Health systems face a persistent financial challenge: Even when revenue and patient activity grow, margins may not follow. Advisory Board's strategic planner survey found that 90% of organizations reported growth in net patient revenue and 79% reported higher patient volume, yet only 60% achieved operating margin gains.¹ In response, provider leaders are placing greater emphasis on operational efficiency, ambulatory expansion, technology investments and sustainable growth strategies.

For life sciences organizations seeking to partner with health systems, those priorities provide a road map for how they can demonstrate value to health systems and integrated delivery networks. Specifically, commercial, sales, and market access teams can strengthen their value story by showing how their products and services help providers pursue differentiated growth, improve operations, shift care to lower-cost settings, and advance priority service lines.